| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/16/2006 | US7045349 Classification of pancreatic islet cells; obtain cells, heat, monitor and classify cell activity |
| 05/16/2006 | US7045347 Helper dependent adenovirus vectors based on integrase family site-specific recombinases |
| 05/16/2006 | US7045346 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 05/16/2006 | US7045345 G-coupled receptor showing selective affinity for ATP |
| 05/16/2006 | US7045337 Translation system for use in the generation of protein containing adjusted amino acid sequences |
| 05/16/2006 | US7045335 Immunotherapy; genetic engineering; anticancer agents |
| 05/16/2006 | US7045332 BGL4 β-glucosidase and nucleic acids encoding the same |
| 05/16/2006 | US7045331 EGVII endoglucanase and nucleic acids encoding the same |
| 05/16/2006 | US7045315 Methods for modulating expression of exogenous genes in mammalian systems |
| 05/16/2006 | US7045304 Contacting a first cell with the compound, determining a first value of a property of the first cell, contacting second cell containing zinc finger protein which modulates expression of the molecular target, determining second value of the cell |
| 05/16/2006 | US7045302 Expressed ligand-vascular intercellular signaling molecule |
| 05/16/2006 | US7045295 Method for collecting purified cells |
| 05/16/2006 | US7045294 Isolated human protease; screening for reduction of gene expression; therapy for dietetics, obesity, antidiabetic agents, cardiovascular disorders |
| 05/16/2006 | US7045284 Reducing translation of Rna virus; genetic engineered nucleic acids |
| 05/16/2006 | US7045279 Isolated perfused heart preparation and method of use |
| 05/16/2006 | US7045148 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 05/16/2006 | US7045129 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3 |
| 05/16/2006 | US7045128 Antibodies against flt3-ligand |
| 05/16/2006 | US7045123 DNA encoding Pseudomonas syringae hypersensitive response elicitor and its use |
| 05/16/2006 | CA2129183C Bispecific trigger molecules recognizing lymphocyte antigen cd2 and tumor antigens |
| 05/15/2006 | CA2502546A1 Sweet potato sporamin gene promoter |
| 05/11/2006 | WO2006050491A2 Methods for antibody engineering |
| 05/11/2006 | WO2006050330A2 Platelets from stem cells |
| 05/11/2006 | WO2006050270A2 Compositions and methods for treating hyperproliferative disorders |
| 05/11/2006 | WO2006050213A2 Methods of promoting healing of cartilage defects and method of causing stem cells to differentiate by the articular chondrocyte pathway |
| 05/11/2006 | WO2006050138A2 Methods of generating antigen-specific cd4+cd25+ regulatory t cells, compositions and methods of use |
| 05/11/2006 | WO2006050050A2 Chemically defined media compositions |
| 05/11/2006 | WO2006049439A1 Method of producing xenogenic cd4 t-cell and animal model producing xenogenic cd4 t-cell |
| 05/11/2006 | WO2006049336A1 Method of preparing stem cells and tissue remedy |
| 05/11/2006 | WO2006049315A1 Lignan glycosidase and utilization of the same |
| 05/11/2006 | WO2006048783A2 Autogenic living scaffolds and living tissue matrices: methods and uses thereof |
| 05/11/2006 | WO2006048459A2 Selection of host cells expressing protein at high levels |
| 05/11/2006 | WO2006048228A1 Method for the generation of virus producing cell lines and cell lines |
| 05/11/2006 | WO2006047954A1 The method of obtaining and applying the materials for autoantigen immunological recognition |
| 05/11/2006 | WO2006013472A3 Novel anti-igf-ir antibodies and uses thereof |
| 05/11/2006 | WO2005117994A3 Bmp pathway methods and compositions |
| 05/11/2006 | WO2005095459A3 Monoclonal antibodies to gastrin hormone |
| 05/11/2006 | WO2005085422A8 Adult stem cells and uses thereof |
| 05/11/2006 | WO2005035734A8 Process for producing cell culture and cell culture |
| 05/11/2006 | WO2005016250A3 Cell therapy for neurometabolic disorders |
| 05/11/2006 | WO2005007797A3 Oligodendrocyte precursor cells and methods of obtaining and culturing the same |
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | US20060101545 Plant stably transformed with recombinant expression construct comprising a soybean promoter and a heterologous nucleic acid fragment operably linked; genetic engineering |
| 05/11/2006 | US20060101544 Phospholipid:diacylglycerol acyltransferases |
| 05/11/2006 | US20060101543 Production of hydroxylated fatty acids in genetically modified plants |
| 05/11/2006 | US20060101539 Cryopreservation of cells |
| 05/11/2006 | US20060101535 DNA construct comprising a promoter linked to gene involved in monolignol biosynthetic pathway |
| 05/11/2006 | US20060101529 Lymphocyte surface receptor that binds CAML and methods of use thereof |
| 05/11/2006 | US20060101528 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment |
| 05/11/2006 | US20060100420 5-hydroxytryptophol (5-HTOL) derivatives, antibodies, immunoassays and detection of recent alcohol consumption |
| 05/11/2006 | US20060100416 Novel substitution mutant receptors and their use in an nuclear receptor-based inducible gene expression system |
| 05/11/2006 | US20060100369 Bifunctional-modified hydrogels |
| 05/11/2006 | US20060100134 fusion proteins; drug delivery |
| 05/11/2006 | US20060100131 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 05/11/2006 | US20060099710 Vector for improved in vivo production of proteins |
| 05/11/2006 | US20060099708 Methods for diagnosis and treatment of MDK1 signal transduction disorders |
| 05/11/2006 | US20060099707 Filtration; solvent exchange; disposable; cassettes |
| 05/11/2006 | US20060099699 Comprises nucleotide sequences coding galactosyltransferase for use in treatment or prevention of aberrant cell surface glycosylation associated with tumor progression |
| 05/11/2006 | US20060099698 Glucose dehydrogenases |
| 05/11/2006 | US20060099688 polypeptides having transferse enzyme activity, used for biosynthesis of polysaccharides; genetic engineering |
| 05/11/2006 | US20060099683 Isolated hOAT polypeptide |
| 05/11/2006 | US20060099682 Human vanilloid receptors and their uses |
| 05/11/2006 | US20060099681 Human and mouse alkaline ceramidase 1 and skin diseases |
| 05/11/2006 | US20060099679 nucleic acids, vectors, and host cells; monomeric fluorescent proteins with increased photostability and the longest-wavelength emissions (e.g., 649 nm) yet observed for a red fluorescent protein |
| 05/11/2006 | US20060099678 Method of inducing homologous recombination of somatic cell |
| 05/11/2006 | US20060099675 Method for preparing an extracellular matrix and its use for tumor cell culture |
| 05/11/2006 | US20060099673 Novel recombinant gene expression method by stop codon suppression |
| 05/11/2006 | US20060099659 Method to detect IgE |
| 05/11/2006 | US20060099658 PCA3, PCA3 genes, and methods of use |
| 05/11/2006 | US20060099651 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 05/11/2006 | US20060099640 SLO2 and SLO4, novel potassium channel proteins from human brain |
| 05/11/2006 | US20060099635 Anti-GL50 antibodies |
| 05/11/2006 | US20060099633 Human FcgammaRIIB gene polymorphisms for assessing development of systemic lupus erythematosus and compositions for use thereof |
| 05/11/2006 | US20060099611 In vivo affinity maturation scheme |
| 05/11/2006 | US20060099597 Method of isolating nucleic acid having desired functional property and kit therefor |
| 05/11/2006 | US20060099595 Culturing an Huh-7.5 cell line (ATCC accession number PTA-8561) that also has a genomic or subgenomic HCV RNA capable of replication, curing with an antiviral agent, and identifying sublines that are permissive for HCV replication. |
| 05/11/2006 | US20060099570 Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle |
| 05/11/2006 | US20060099568 Signals and molecular species involved in senescence |
| 05/11/2006 | US20060099224 Methods and compositions concerning poxviruses and cancer |
| 05/11/2006 | US20060099215 Walnut and ryegrass allergens |
| 05/11/2006 | US20060099209 prostate and breast carcinoma; used for diagnosis to identify individuals with the high probability of having a malignant disease |
| 05/11/2006 | US20060099204 humanizing a rabbit antibody; to change the amino acid sequence of a CDR without significantly reducing the affinity of the antibody of the antibody |
| 05/11/2006 | US20060099203 B7-DC binding antibody |
| 05/11/2006 | US20060099198 Platelets from stem cells |
| 05/11/2006 | US20060099195 Tumor cells with increased immunogenicity and uses therfor |
| 05/11/2006 | US20060099193 Methods and materials for suppressing pain |
| 05/11/2006 | US20060099192 Method for generating an expandable tissue culture from progenitor cells and tissue so generated |
| 05/11/2006 | US20060099191 Cell-seeded tissue-engineered polymers for treatment of intracranial aneurysms |
| 05/11/2006 | US20060099190 Method for transdifferentiating mesenchymal stem cells into neuronal cells |
| 05/11/2006 | US20060099187 Expression vector includes insert of dna which codes for exogenous protein and adenovirus dna having deletion from nucleotides 356-4020; production of recombinant proteins; gene therapy against tumors and cancer |
| 05/11/2006 | US20060099185 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 05/11/2006 | US20060099184 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors |
| 05/11/2006 | US20060099177 Methods for treating HIV infected subjects |
| 05/11/2006 | US20060099143 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| 05/11/2006 | DE60204699T2 Verfahren zur selektion von zellen die antikörper exprimieren A process for the selection of cells expressing antibodies |
| 05/11/2006 | DE3571648C5 Monoklonale Antikörper gegen menschlichen Brustkrebs, ihre Produktion und Verwendung, Hybridomen zu ihrer Herstellung und Herstellung dieser Hybridomen. Monoclonal antibodies against human breast cancer, their production and use, hybridomas for their preparation and production of these hybridomas. |
| 05/11/2006 | DE102004054536A1 Multimodal veränderte Zellen als zellulare Darreichungsformen für aktive Substanzen und als diagnostische Zellpartikel Multimodal modified cells as cellular forms for active substances and as diagnostic cell particles |
| 05/11/2006 | CA2589034A1 Compositions and methods for treating hyperproliferative disorders |
| 05/11/2006 | CA2586053A1 Platelets from stem cells |
| 05/11/2006 | CA2585547A1 Chemically defined media compositions |